— Know what they know.
Not Investment Advice

PRLD NASDAQ

Prelude Therapeutics Incorporated
1W: -5.4% 1M: -32.4% 3M: -26.4% YTD: +34.4% 1Y: +143.1% 3Y: +19.5% 5Y: -89.4%
$3.67
-0.12 (-3.17%)
 
Weekly Expected Move ±9.4%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 34 · $208.9M mcap · 42M float · 1.14% daily turnover · Short 69% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
38.1 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 14236.3%
Cost Advantage ★
48
Intangibles
37
Switching Cost
35
Network Effect
43
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PRLD has No discernible competitive edge (38.1/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. ROIC of 14236.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$8
Avg Target
$8
High
Based on 1 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 5Hold: 1Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$8.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-27 H.C. Wainwright — $5 $8 +3 +70.2% $4.70
2024-09-10 H.C. Wainwright Robert Burns $15 $5 -10 -3.3% $5.17
2024-06-20 Barclays Peter Lawson Initiated $3 — -22.5% $3.87
2024-03-12 JMP Securities Reni Benjamin Initiated $7 — +51.5% $4.62
2022-11-17 H.C. Wainwright — Initiated $15 — +94.8% $7.70
2022-11-15 Morgan Stanley — Initiated $10 — +23.5% $8.10

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
3
ROE
1
ROA
1
D/E
2
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PRLD receives an overall rating of C. Areas of concern: ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-03-11 C- C
2026-03-10 C C-
2026-01-22 C+ C
2026-01-20 C C+
2026-01-15 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 37 Grade D
Profitability
20
Balance Sheet
88
Earnings Quality
47
Growth
88
Value
36
Momentum
80
Safety
15
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PRLD scores highest in Balance Sheet (88/100) and lowest in Safety (15/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.23
Distress Zone
Piotroski F-Score
5/9
✗ ✗ ✓ ✓ ✓ ✓ ✗ ✗ ✓
Beneish M-Score
—
—
Ohlson O-Score
-6.21
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BB+
Score: 48.8/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.55x
Accruals: -17.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PRLD scores 0.23, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PRLD scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PRLD's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PRLD receives an estimated rating of BB+ (score: 48.8/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-4.65x
PEG
-0.06x
P/S
9.32x
P/B
2.70x
P/FCF
-15.77x
P/OCF
—
EV/EBITDA
-6.63x
EV/Revenue
17.41x
EV/EBIT
-6.45x
EV/FCF
-11.74x
Earnings Yield
-11.53%
FCF Yield
-6.34%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. PRLD currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
-2.697
EBIT / Rev
×
Asset Turnover
0.147
Rev / Assets
×
Equity Multiplier
1.452
Assets / Equity
=
ROE
-57.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PRLD's ROE of -57.7% is driven by Asset Turnover (0.147), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1512 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$3.67
Median 1Y
$1.40
5th Pctile
$0.20
95th Pctile
$9.87
Ann. Volatility
112.8%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Krishna Vaddi, Ph.D.
Chief Executive Officer
$615,441 $— $1,348,000
Bryant D. Lim
Chief Legal Officer, Corporate Secretary, and Chief Financial Officer
$477,500 $— $847,397
Peggy A. Scherle,
Ph. D. Chief Scientific Officer
$473,416 $— $819,729

CEO Pay Ratio

5:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,348,000
Avg Employee Cost (SGA/emp): $283,620
Employees: 79

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
79
-39.7% YoY
Revenue / Employee
$153,671
Rev: $12,140,000
Profit / Employee
$-1,259,468
NI: $-99,498,000
SGA / Employee
$283,620
Avg labor cost proxy
R&D / Employee
$1,193,671
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -36.4% -44.8% -38.8% -41.9% -45.3% -48.0% -52.0% -46.4% -51.5% -56.3% -65.0% -58.4% -66.6% -69.0% -81.4% -96.3% -1.0% -99.5% -95.2% -57.7% -57.73%
ROA -34.4% -42.3% -36.9% -39.6% -41.7% -43.9% -47.5% -43.3% -46.9% -48.9% -56.4% -51.4% -57.7% -56.1% -65.8% -73.3% -76.6% -62.8% -59.6% -39.8% -39.76%
ROIC 10.6% 25.0% 45.3% 26.8% 18.5% 21.9% -21.8% -12.4% -12.3% -5.0% -4.1% -5.4% -5.4% -7.0% -5.0% -5.2% -4.5% 4.9% 18.2% 142.4% 142.36%
ROCE -32.2% -39.8% -46.1% -50.8% -55.8% -62.1% -68.5% -47.2% -53.1% -50.0% -58.0% -68.7% -79.4% -93.2% -1.2% -1.4% -1.6% -1.2% -1.0% -40.0% -39.97%
Gross Margin — — — — — — — — — — — — 1.0% 1.0% — — 93.5% 1.0% 91.5% 1.0% 1.00%
Operating Margin — — — — — — — — — — — — -11.5% -8.5% — — -3.1% -3.1% -3.1% -2.7% -2.71%
Net Margin — — — — — — — — — — — — -10.8% -7.2% — — -3.0% -2.9% -2.3% -2.4% -2.44%
EBITDA Margin — — — — — — — — — — — — -11.3% -8.3% — — -3.0% -2.8% -2.2% -2.4% -2.38%
FCF Margin — — — — — — — — — — — — -35.9% -14.8% -15.1% -15.5% -9.6% -4.6% -2.6% -1.5% -1.48%
OCF Margin — — — — — — — — — — — — -35.2% -14.7% -15.0% -15.5% -9.5% -4.6% -2.6% -1.5% -1.48%
ROE 3Y Avg snapshot only -93.47%
ROE 5Y Avg snapshot only -74.98%
ROA 3Y Avg snapshot only -66.01%
ROIC Economic snapshot only -35.28%
Cash ROA snapshot only -17.56%
NOPAT Margin snapshot only -2.37%
Pretax Margin snapshot only -2.70%
R&D / Revenue snapshot only 3.10%
SGA / Revenue snapshot only 87.29%
SBC / Revenue snapshot only 36.99%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -14.76 -5.16 -2.71 -2.05 -2.62 -2.51 -2.39 -2.17 -1.78 -2.44 -2.86 -2.22 -1.19 -0.76 -0.46 -0.49 -0.98 -1.83 -3.63 -8.67 -4.646
P/S Ratio — — — — — — — — — — — — 52.34 13.77 8.34 8.79 10.44 15.04 16.88 23.39 9.318
P/B Ratio 4.65 2.02 1.24 1.02 1.44 1.48 1.55 0.97 0.88 1.25 1.70 1.58 1.00 0.73 0.57 0.81 1.87 2.66 4.69 3.92 2.700
P/FCF -19.30 -6.72 -3.55 -2.73 -3.51 -3.34 -2.87 -2.43 -1.91 -2.69 -3.21 -2.71 -1.46 -0.93 -0.55 -0.57 -1.09 -3.24 -6.45 -15.77 -15.769
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -11.36 -2.55 -0.50 -0.02 -0.75 -0.73 -0.84 0.01 0.17 -0.64 -1.32 -0.93 -0.16 0.14 0.16 -0.05 -0.61 -0.96 -2.83 -6.63 -6.626
EV/Revenue — — — — — — — — — — — — 7.18 -2.74 -3.26 0.89 6.91 8.00 13.06 17.41 17.406
EV/EBIT -11.27 -2.53 -0.50 -0.02 -0.74 -0.72 -0.83 0.01 0.16 -0.63 -1.31 -0.92 -0.15 0.14 0.16 -0.05 -0.60 -0.94 -2.77 -6.45 -6.453
EV/FCF -15.05 -3.35 -0.66 -0.03 -1.02 -1.03 -1.07 0.01 0.19 -0.73 -1.56 -1.19 -0.20 0.19 0.22 -0.06 -0.72 -1.72 -4.99 -11.74 -11.737
Earnings Yield -6.8% -19.4% -36.9% -48.8% -38.1% -39.9% -41.8% -46.1% -56.2% -41.0% -35.0% -45.0% -83.8% -1.3% -2.2% -2.0% -1.0% -54.5% -27.6% -11.5% -11.53%
FCF Yield -5.2% -14.9% -28.2% -36.7% -28.5% -30.0% -34.9% -41.2% -52.2% -37.2% -31.1% -36.9% -68.5% -1.1% -1.8% -1.8% -91.5% -30.9% -15.5% -6.3% -6.34%
Price/Tangible Book snapshot only 3.921
EV/Gross Profit snapshot only 18.063
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 16.57 15.37 16.80 15.72 10.52 9.42 8.91 17.13 13.91 10.79 11.64 7.83 7.04 5.30 5.18 3.68 3.21 1.99 2.03 4.07 4.072
Quick Ratio 16.57 15.37 16.80 15.72 10.52 9.42 8.91 17.13 13.91 10.79 11.64 7.83 7.04 5.30 5.18 3.68 3.21 1.99 2.03 4.07 4.072
Debt/Equity 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.07 0.08 0.10 0.12 0.14 0.17 0.24 0.31 0.26 0.29 0.13 0.132
Net Debt/Equity -1.02 -1.01 -1.01 -1.02 -1.02 -1.02 -0.97 -0.97 -0.97 -0.91 -0.87 -0.89 -0.87 -0.88 -0.79 -0.73 -0.63 -1.24 -1.06 -1.00 -1.003
Debt/Assets 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.06 0.07 0.08 0.09 0.10 0.13 0.16 0.19 0.13 0.15 0.09 0.093
Debt/EBITDA -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.00 -0.13 -0.13 -0.13 -0.13 -0.13 -0.13 -0.13 -0.15 -0.18 -0.23 -0.30 -0.300
Net Debt/EBITDA 3.21 2.57 2.18 2.00 1.83 1.64 1.41 2.05 1.81 1.70 1.40 1.18 0.99 0.84 0.59 0.42 0.31 0.84 0.83 2.28 2.277
Interest Coverage — — — — — — — — — — — — — — — — — — — — —
Equity Multiplier 1.06 1.07 1.07 1.08 1.11 1.13 1.13 1.07 1.09 1.17 1.17 1.23 1.26 1.34 1.37 1.52 1.62 2.06 1.99 1.42 1.416
Cash Ratio snapshot only 3.989
Cash to Debt snapshot only 8.598
FCF to Debt snapshot only -1.884
Defensive Interval snapshot only 622.3 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.03 0.04 0.04 0.07 0.08 0.13 0.15 0.147
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover — — — — — — — — — — — — — — — — — — — — —
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.05 0.06 0.06 0.00 0.00 0.00 0.10 0.07 0.21 0.23 0.233
DSO — — — — — — — — — — — — 0 0 0 0 0 0 0 0 0.0 days
DIO — — — — — — — — — 0 0 0 0 — — — 0 0 0 0 0.0 days
DPO — — — — — — — — — 6262 6831 6481 6115 — — — 3630 5031 1767 1564 1564.2 days
Cash Conversion Cycle — — — — — — — — — — — — -6115 — — — -3630 -5031 -1767 -1564 -1564.2 days
Fixed Asset Turnover snapshot only 0.728
Cash Velocity snapshot only 0.148
Capital Intensity snapshot only 8.445
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — — — — — — — — — — — — — 2.5% 73.4% 1.4% 2.2% 2.20%
Net Income -4.9% -2.1% -1.1% -43.0% -22.0% -3.4% 5.1% 3.0% 1.9% -5.5% -10.4% -11.2% -12.0% -4.4% -1.8% 4.3% 15.0% 21.8% 39.1% 51.3% 51.34%
EPS -3.8% -1.5% -1.0% -39.3% -19.1% 0.0% 6.5% 18.5% 31.2% 27.4% 30.4% 17.4% 0.1% 4.3% -1.5% 4.6% 15.3% 5.7% 44.0% 62.4% 62.42%
FCF -4.9% -2.1% -1.0% -38.7% -19.2% -1.0% -3.6% -15.2% -22.1% -27.5% -17.8% -2.1% 1.5% 6.3% 5.2% -1.9% 6.8% 45.6% 58.6% 69.4% 69.36%
EBITDA -4.5% -2.0% -1.0% -41.0% -22.6% -8.3% -0.1% -1.3% -4.2% -3.8% -8.9% -10.0% -8.1% -8.8% -4.8% 2.4% 13.7% 26.6% 44.2% 55.8% 55.79%
Op. Income -4.5% -2.0% -1.0% -41.3% -23.0% -8.6% -0.3% -1.4% -4.2% -7.1% -12.4% -13.5% -11.7% -5.6% -1.8% 5.1% 15.5% 25.2% 39.9% 50.1% 50.08%
OCF Growth snapshot only 69.31%
Asset Growth snapshot only 64.78%
Equity Growth snapshot only 76.34%
Debt Growth snapshot only -1.49%
Shares Change snapshot only 29.47%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — — — — — — — — — — —
Revenue 5Y — — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — 2.6% 7.5% -12.6% -13.8% -15.9% -16.8% -20.5% -23.7% -26.9% -13.8% -15.5% -12.3% -12.29%
Assets 5Y — — — — — — — — — — — — — — — — -16.9% -8.8% -20.2% -11.5% -11.54%
Equity 3Y — — — — — — — — 1.4% 3.8% -16.1% -18.3% -20.5% -22.8% -26.7% -32.0% -35.4% -29.4% -30.0% -20.1% -20.09%
Book Value 3Y — — — — — — — — -16.3% -15.1% -29.4% -30.8% -32.5% -34.5% -37.5% -41.9% -44.8% -35.6% -41.7% -33.7% -33.68%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.60 0.60 0.60 0.60 0.58 0.68 0.64 0.59 0.595
Earnings Stability — — — — 0.90 0.79 0.67 0.67 0.74 0.70 0.66 0.75 0.72 0.66 0.63 0.62 0.54 0.35 0.06 0.03 0.033
Margin Stability — — — — — — — — — — — — — — — — — — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — 0.91 0.99 0.98 0.99 0.99 0.98 0.96 0.96 0.95 0.98 0.99 0.98 0.94 0.91 0.84 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — -0.36 -0.31 -0.34 -0.07 -0.06 -0.02 -0.04 -0.24 -0.32 -0.42 -0.62 -1.06 -1.24 -0.71 -0.38 0.72 0.724
Gross Margin Trend — — — — — — — — — — — — — — — — — — — — —
FCF Margin Trend — — — — — — — — — — — — — — — — — — — — —
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.74 0.75 0.74 0.73 0.72 0.73 0.81 0.87 0.91 0.88 0.87 0.80 0.80 0.81 0.82 0.87 0.90 0.57 0.56 0.55 0.550
FCF/OCF 1.03 1.03 1.03 1.03 1.03 1.04 1.03 1.03 1.03 1.03 1.03 1.02 1.02 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 0.550
CapEx/Revenue — — — — — — — — — — — — 61.3% 10.9% 7.5% 2.6% 1.1% 0.6% 0.1% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -0.09 -0.11 -0.09 -0.11 -0.12 -0.12 -0.09 -0.06 -0.04 -0.06 -0.08 -0.10 -0.11 -0.11 -0.12 -0.09 -0.08 -0.27 -0.26 -0.18 -0.179
Sloan Accruals snapshot only 0.390
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -11.1% -28.3% -0.6% -1.0% -0.8% -0.2% -0.1% -43.9% -53.2% -45.8% -38.0% -8.7% -15.9% -0.2% -0.3% -0.4% -0.2% -13.7% -8.9% -22.0% -21.96%
Total Shareholder Return -11.1% -28.3% -0.6% -1.0% -0.8% -0.2% -0.1% -43.9% -53.2% -45.8% -38.0% -8.7% -15.9% -0.2% -0.3% -0.4% -0.2% -13.7% -8.9% -22.0% -21.96%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.98 0.98 0.98 0.97 0.97 0.93 0.93 0.93 0.92 0.95 0.94 0.94 0.95 0.91 0.91 0.92 0.93 0.97 0.99 1.00 1.000
EBIT Margin — — — — — — — — — — — — -46.32 -19.96 -20.00 -19.29 -11.46 -8.48 -4.71 -2.70 -2.697
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.03 0.04 0.04 0.07 0.08 0.13 0.15 0.147
Equity Multiplier 1.06 1.06 1.05 1.06 1.08 1.09 1.10 1.07 1.10 1.15 1.15 1.14 1.15 1.23 1.24 1.31 1.36 1.58 1.60 1.45 1.452
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-2.12 $-2.41 $-2.55 $-2.55 $-2.52 $-2.41 $-2.38 $-2.08 $-1.74 $-1.75 $-1.66 $-1.71 $-1.73 $-1.68 $-1.68 $-1.64 $-1.47 $-1.58 $-0.94 $-0.61 $-0.61
Book Value/Share $6.72 $6.17 $5.56 $5.09 $4.58 $4.08 $3.67 $4.66 $3.52 $3.41 $2.78 $2.41 $2.06 $1.73 $1.36 $1.00 $0.77 $1.09 $0.73 $1.36 $1.36
Tangible Book/Share $6.72 $6.17 $5.56 $5.09 $4.58 $4.08 $3.67 $4.66 $3.52 $3.41 $2.78 $2.41 $2.06 $1.73 $1.36 $1.00 $0.77 $1.09 $0.73 $1.36 $1.36
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.04 $0.09 $0.09 $0.09 $0.14 $0.19 $0.20 $0.23 $0.23
FCF/Share $-1.62 $-1.85 $-1.95 $-1.91 $-1.88 $-1.81 $-1.99 $-1.85 $-1.61 $-1.59 $-1.48 $-1.41 $-1.42 $-1.37 $-1.39 $-1.43 $-1.32 $-0.90 $-0.53 $-0.34 $-0.34
OCF/Share $-1.57 $-1.80 $-1.90 $-1.86 $-1.82 $-1.75 $-1.93 $-1.80 $-1.57 $-1.54 $-1.44 $-1.37 $-1.39 $-1.36 $-1.39 $-1.43 $-1.32 $-0.89 $-0.53 $-0.34 $-0.34
Cash/Share $6.93 $6.29 $5.66 $5.21 $4.72 $4.21 $3.61 $4.53 $3.41 $3.35 $2.67 $2.37 $2.03 $1.76 $1.30 $0.96 $0.72 $1.64 $0.99 $1.54 $1.54
EBITDA/Share $-2.15 $-2.44 $-2.57 $-2.59 $-2.57 $-2.55 $-2.54 $-2.21 $-1.88 $-1.82 $-1.74 $-1.80 $-1.81 $-1.82 $-1.82 $-1.75 $-1.56 $-1.61 $-0.93 $-0.60 $-0.60
Debt/Share $0.05 $0.04 $0.05 $0.04 $0.03 $0.04 $0.03 $0.02 $0.01 $0.24 $0.23 $0.24 $0.24 $0.24 $0.24 $0.24 $0.23 $0.28 $0.21 $0.18 $0.18
Net Debt/Share $-6.88 $-6.25 $-5.61 $-5.17 $-4.69 $-4.17 $-3.58 $-4.52 $-3.40 $-3.10 $-2.43 $-2.13 $-1.79 $-1.52 $-1.07 $-0.73 $-0.49 $-1.36 $-0.77 $-1.36 $-1.36
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 0.231
Altman Z-Prime snapshot only -0.378
Piotroski F-Score 1 1 1 1 2 1 2 4 4 3 3 1 2 2 2 2 2 4 3 5 5
Beneish M-Score — — — — — — — — — — — — — — — — -1.98 -3.55 — — —
Ohlson O-Score snapshot only -6.213
ROIC (Greenblatt) snapshot only -40.97%
Net-Net WC snapshot only $1.01
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB+
Credit Score 72.98 74.13 74.73 75.63 75.61 74.34 70.39 76.11 70.65 54.45 59.53 44.23 44.45 44.10 44.12 43.07 42.75 39.17 41.66 48.82 48.822
Credit Grade snapshot only 11
Credit Trend snapshot only 5.747
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 46
Sector Credit Rank snapshot only 42

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms